- Outcomes of Mavacamten Treatment in Adolescents With Obstructive Hypertrophic Cardiomyopathy at 56 Weeks: The SCOUT-HCM Trial
-
C. Wolf{1}, J. Rossano{2}, M. Y. Desai{3}, J. Yang{4}, R. Aronson{4}, S. Mital{5}, C. Canter{6};Generic 'disconnected' Message
{1}German Heart Center, Munich, Germany, {2}Children's Hospital of Philadelphia, Philadelphia, PA, {3}Cleveland Clinic, Cleveland, OH, {4}Bristol Myers Squibb, Princeton, NJ, {5}The Hospital for Sick Children, Toronto, ON, Canada, {6}Washington University School of Medicine, St. Louis, MOCommunitiesNavigationSession TypeOnsite Viewing
Enter Note
Go to previous page in this tab
Session


